Form D · Other Health Care
VenoStent, Inc.
Houston, TX · CIK 0001734734
Offering snapshot reported May 1, 2026 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Apr 10, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 1, 2026 | Initial | $10,000,000 | No comparison | 29 | SEC filing |
| Jul 19, 2023 | Initial | $16,062,824 | No comparison | 60 | SEC filing |
| Feb 16, 2021 | Initial | $2,242,619 | No comparison | 24 | SEC filing |
| Jun 10, 2020 | Initial | $515,000 | No comparison | 16 | SEC filing |
| Jul 10, 2019 | Initial | $263,929 | No comparison | 8 | SEC filing |
| Mar 22, 2018 | Initial | $70,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-582632
Source: Form D, filed May 1, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Boire | Director, Executive |
| Robert Crutchfield | Director |
| Geoffrey Lucks | Director, Executive |
| Jim Monsor | Director |
| Kulika Weizman | Director |
| Joel Whitley | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2450 Holcombe Blvd. Suite B
Houston, TX, 77021
Houston, TX, 77021